About 80% of lung cancers are non-small cell lung cancers (NSCLCs), and epidermal growth factor receptor (EGFR) gene mutations are considered to prompt NSCLC development (Sharma et al., 2007). This evidence concerns the gene EGFR and non-small cell lung carcinoma.